![glp 1 saxenda Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves First Generic GLP-1](https://photos.prnewswire.com/prnfull/20150421/200098)
glp 1 saxenda
Shipping Estimate
glp 1 saxenda Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves First Generic GLP-1
EUR23.54
EUR43.54
Pay in 4 interest-free payments of $5.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
![glp 1 saxenda Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves First Generic GLP-1](https://cdn.sanity.io/images/0vv8moc6/drugtopics/95e97d281e5924cde2da30014f9dab359d32abfa-7200x3600.jpg)
![glp 1 saxenda Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves First Generic GLP-1](https://www.cityofnewburyport.com/sites/g/files/vyhlif12211/f/styles/news_image/public/news/glp_1_pens.original.png?itok=3edRkhqK)
![glp 1 saxenda Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves First Generic GLP-1](https://unnatipharmax.com/wp-content/uploads/2025/09/Tashko-GLP1-1986-Discovery-169-1024x576-1.png)
![glp 1 saxenda Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves First Generic GLP-1](https://cdn.prod.website-files.com/660dbd9edac735ff882da2d3/665e4131101a210ec529311b_Saxenda%20Pen%201.png)
![glp 1 saxenda Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves First Generic GLP-1](https://nurx-www.imgix.net/wp-content/uploads/2025/02/27075643/Saxenda-Liraglutide-PDP-1000x1000-1.png?w=320&auto=format,compress&fit=crop&h=320)
![glp 1 saxenda Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves First Generic GLP-1](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2025/08/shutterstock_2365011949.jpg)
